Autoimmunerkrankungen sind eine Gruppe von Erkrankungen, bei welchen ein gestörtes Immunsystem zu einer Störung körpereigener Funktionen führt.
1. |
Wu H et al. (2007) Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. |
3. |
Boteva L et al. (2012) Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations. |
4. |
Barreto M et al. (2004) Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. |
5. |
Lee YH et al. (2005) CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. |
6. |
Napirei M et al. (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. |
7. |
Yasutomo K et al. (2001) Mutation of DNASE1 in people with systemic lupus erythematosus. |
8. |
Shin HD et al. (2004) Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients. |
9. |
Balada E et al. (2008) Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus. |
10. |
Sanghera DK et al. (1997) Identification of structural mutations in the fifth domain of apolipoprotein H (beta 2-glycoprotein I) which affect phospholipid binding. |
11. |
Linker-Israeli M et al. (1999) Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression. |
12. |
Lee YH et al. (2006) Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility. |
13. |
Hom G et al. (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. |
14. |
Guiducci C et al. (2010) TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. |
15. |
Prokunina L et al. (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. |
16. |
Remmers EF et al. (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. |
17. |
Han JW et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. |
18. |
Gateva V et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. |
19. |
Kyogoku C et al. (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. |
20. |
Orrú V et al. (2009) A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. |
21. |
Kyogoku C et al. (2002) Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. |
23. |
McGaha TL et al. (2005) Restoration of tolerance in lupus by targeted inhibitory receptor expression. |
24. |
Blank MC et al. (2005) Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus. |
25. |
Floto RA et al. (2005) Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. |
26. |
Willcocks LC et al. (2010) A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus. |
27. |
Mueller M et al. (2013) Genomic pathology of SLE-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus. |
28. |
Leadbetter EA et al. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. |
29. |
Lee-Kirsch MA et al. (2007) Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. |
30. |
Sigurdsson S et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. |
31. |
Graham RR et al. (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. |
32. |
Yocum MW et al. () Monozygotic twins discordant for systemic lupus erythematosus. |
33. |
Beaucher WN et al. (1977) Familial lupus erythematosus. Antibodies to DNA in household dogs. |
34. |
Horn JR et al. () Mixed connective tissue disease in siblings. |
35. |
Miller KB et al. (1979) Familial abnormalities of suppressor-cell function in systemic lupus erythematosus. |
36. |
None (1979) Systemic lupus erythematosus, autoimmunity, sex and inheritance. |
37. |
Serdula MK et al. (1979) Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. |
38. |
Brustein D et al. (1977) Familial lupus erythematosus. |
39. |
Knight JG et al. (1978) Three genes for lupus nephritis in NZB x NZW mice. |
40. |
Arnett FC et al. (1976) Studies in familial systemic lupus erythematosus. |
41. |
DeHoratius RJ et al. (1975) Anti-nucleic acid antibodies in systemic lupus erythematosus patients and their families. Incidence and correlation with lymphocytotoxic antibodies. |
42. |
Block SR et al. (1975) Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. |
43. |
Sturfelt G et al. (1990) Homozygous C4A deficiency in systemic lupus erythematosus: analysis of patients from a defined population. |
44. |
Stohl W et al. (1985) Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cells. |
45. |
Sakane T et al. (1989) Familial occurrence of impaired interleukin-2 activity and increased peripheral blood B cells actively secreting immunoglobulins in systemic lupus erythematosus. |
46. |
Wong DW et al. (1988) Nonlinkage of the T cell receptor alpha, beta, and gamma genes to systemic lupus erythematosus in multiplex families. |
47. |
Levcovitz H et al. (1988) Segregation of lymphocyte low-molecular-weight DNA and antinuclear-antibodies in a family with systemic lupus erythematosus in first cousins. |
48. |
Green JR et al. (1986) The association of HLA-linked genes with systemic lupus erythematosus. |
49. |
Mackie IJ et al. (1987) Familial lupus anticoagulants. |
50. |
Baer AN et al. (1986) Further evidence for the lack of association between acetylator phenotype and systemic lupus erythematosus. |
51. |
Fronek Z et al. (1986) Systemic lupus erythematosus is not genetically linked to the beta chain of the T cell receptor. |
52. |
Halpern R et al. (1985) Familial systemic lupus erythematosus. Presence of a cross-reactive idiotype in healthy family members. |
53. |
Theofilopoulos AN et al. (1985) Murine models of systemic lupus erythematosus. |
54. |
None (1971) Lupus erythematosus panniculitis (profundus). |
55. |
None (1972) Family studies in systemic lupus erythematosus. I. A proband material from central eastern Norway. |
56. |
Siegel M et al. (1965) A comparative family study of rheumatoid arthritis and systemic lupus erythematosus. |
57. |
Lappat EJ et al. (1968) A familial study of procainamide-induced systemic lupus erythematosus. A question of pharmacogenetic polymorphism. |
58. |
None (1974) Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. |
59. |
Reed WB et al. (1972) Hereditary inflammatory vasculitis with persistent nodules. A genetically-determined new entity probably related to lupus erythematosus. |
60. |
Kohler PF et al. (1974) Hereditary angioedema and "familial" lupus erythematosus in identical twin boys. |
61. |
None (1973) Familial systemic lupus erythematosus. |
62. |
None (1972) Illness resembling lupus erythematosus in mothers of boys with chronic granulomatous disease. |
63. |
Larsen RA et al. (1972) Family studies in systemic lupus erythematosus (SLE). IX. Thyroid diseases and antibodies. |
64. |
Siegel M et al. () Epidemiologic studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956-1965. |
65. |
Batchelor JR et al. (1980) Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. |
66. |
Solomon G et al. (1983) Use of monoclonal antibodies to identify shared idiotypes on human antibodies to native DNA from patients with systemic lupus erythematosus. |
67. |
Steinberg AD et al. (1984) NIH conference. Systemic lupus erythematosus: insights from animal models. |
68. |
Hughes GR et al. (1983) Genetics of systemic lupus erythematosus. |
70. |
Diamond B et al. (1984) Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity. |
71. |
Reveille JD et al. (1983) Familial systemic lupus erythematosus: immunogenetic studies in eight families. |
72. |
Lahita RG et al. (1983) Familial systemic lupus erythematosus in males. |
73. |
Tan EM et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. |
74. |
Reidenberg MM et al. (1980) Acetylator phenotype in idiopathic systemic lupus erythematosus. |
75. |
Exner T et al. (1980) Familial association of the lupus anticoagulant. |
76. |
Weinberg JB et al. (1980) Analysis of a large pedigree with elliptocytosis, multiple lipomatosis, and biological false-positive serological test for syphilis. |
77. |
Morel L et al. (1994) Polygenic control of susceptibility to murine systemic lupus erythematosus. |
78. |
Sibley JT et al. (1993) Familial systemic lupus erythematosus characterized by digital ischemia. |
79. |
None (1996) Systemic lupus erythematosus. |
80. |
Vyse TJ et al. (1996) Genetic analysis of autoimmune disease. |
81. |
None (1995) Genetics of systemic lupus erythematosus. |
82. |
Wu J et al. (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. |
83. |
Vyse TJ et al. (1996) Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice. |
84. |
García CO et al. (1996) Autoantibody profile in African-American patients with lupus nephritis. |
85. |
Lessard E et al. (1997) Role of CYP2D6 in the N-hydroxylation of procainamide. |
86. |
Elçioglu N et al. (1998) Maternal systemic lupus erythematosus and chondrodysplasia punctata in two sibs: phenocopy or coincidence? |
87. |
Austin-Ward E et al. (1998) Neonatal lupus syndrome: a case with chondrodysplasia punctata and other unusual manifestations. |
88. |
None (1998) Chondrodysplasia punctata and maternal systemic lupus erythematosus. |
89. |
Gaffney PM et al. (1998) A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. |
90. |
Shai R et al. (1999) Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. |
91. |
Kelly TE et al. (1999) Chondrodysplasia punctata stemming from maternal lupus erythematosus. |
92. |
Mohan C et al. (1999) Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. |
93. |
Lessard E et al. (1999) Involvement of CYP2D6 activity in the N-oxidation of procainamide in man. |
94. |
Lindqvist AK et al. (2000) A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. |
95. |
Gaffney PM et al. (2000) Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families. |
96. |
Gross JA et al. (2000) TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. |
97. |
Gray-McGuire C et al. (2000) Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2. |
98. |
Zhang J et al. (2001) Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. |
99. |
Solomou EE et al. (2001) Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. |
100. |
DeGiorgio LA et al. (2001) A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. |
101. |
Blanco P et al. (2001) Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. |
102. |
Stein CM et al. (2002) Increased prevalence of renal disease in systemic lupus erythematosus families with affected male relatives. |
103. |
Graham RR et al. (2002) Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. |
104. |
Quintero-Del-Rio AI et al. (2002) The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3). |
105. |
Kelly JA et al. (2002) The genetics of systemic lupus erythematosus: putting the pieces together. |
106. |
Johanneson B et al. (2002) A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31. |
107. |
Scofield RH et al. (2003) Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q22 and 11p13. |
108. |
Sun Y et al. (2002) Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. |
109. |
Molokhia M et al. (2003) Relation of risk of systemic lupus erythematosus to west African admixture in a Caribbean population. |
110. |
Baechler EC et al. (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. |
111. |
Nakamura K et al. (2003) Genetic dissection of anxiety in autoimmune disease. |
112. |
None (1964) ANTINUCLEAR ANTIBODIES IN FAMILIES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. |
113. |
Kamat SS et al. (2003) Triplets with systemic lupus erythematosus. |
114. |
Russell AI et al. (2004) Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. |
115. |
Li N et al. (2004) Gain-of-function polymorphism in mouse and human Ltk: implications for the pathogenesis of systemic lupus erythematosus. |
116. |
Xu L et al. (2004) Human lupus T cells resist inactivation and escape death by upregulating COX-2. |
117. |
Tournoy J et al. (2004) Partial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice. |
118. |
Kozlowski K et al. (2004) Chondrodysplasia punctata in siblings and maternal lupus erythematosus. |
119. |
Tao D et al. (2005) CD226 expression deficiency causes high sensitivity to apoptosis in NK T cells from patients with systemic lupus erythematosus. |
120. |
Barber DF et al. (2005) PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. |
121. |
Xing C et al. (2005) Genetic linkage of systemic lupus erythematosus to 13q32 in African American families with affected male members. |
122. |
Lee YH et al. (2005) Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. |
123. |
Huerta PT et al. (2006) Immunity and behavior: antibodies alter emotion. |
124. |
Aitman TJ et al. (2006) Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. |
125. |
Kowal C et al. (2006) Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. |
126. |
Fanciulli M et al. (2007) FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. |
127. |
Kamatani Y et al. (2008) Identification of a significant association of a single nucleotide polymorphism in TNXB with systemic lupus erythematosus in a Japanese population. |
128. |
Cunninghame Graham DS et al. (2008) Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. |
129. |
et al. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. |
130. |
Kozyrev SV et al. (2008) Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. |
131. |
Nath SK et al. (2008) A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. |
132. |
Oishi T et al. (2008) A functional SNP in the NKX2.5-binding site of ITPR3 promoter is associated with susceptibility to systemic lupus erythematosus in Japanese population. |
133. |
Willcocks LC et al. (2008) Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. |
134. |
Graham RR et al. (2008) Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. |
135. |
Musone SL et al. (2008) Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. |
136. |
Sthoeger ZM et al. (2009) High alpha-defensin levels in patients with systemic lupus erythematosus. |
137. |
Sánchez E et al. (2009) Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus. |
138. |
Myouzen K et al. (2010) Regulatory polymorphisms in EGR2 are associated with susceptibility to systemic lupus erythematosus. |
139. |
Niederer HA et al. (2010) Copy number, linkage disequilibrium and disease association in the FCGR locus. |
140. |
Olsson LM et al. (2012) Copy number variation of the gene NCF1 is associated with rheumatoid arthritis. |
141. |
Manjarrez-Orduño N et al. (2012) CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. |
142. |
Kshirsagar S et al. (2014) Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis. |
143. |
Talaei N et al. (2015) Identification of the SLAM Adapter Molecule EAT-2 as a Lupus-Susceptibility Gene That Acts through Impaired Negative Regulation of Dendritic Cell Signaling. |
144. |
Zhao J et al. (2017) A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. |
145. |
Bialas AR et al. (2017) Microglia-dependent synapse loss in type I interferon-mediated lupus. |